Bausch & Lomb, Arrow shareholders approve buy-out offers:
This article was originally published in Clinica
Warburg Pincus has won over Bausch & Lomb's shareholders, who last week approved the private equity firm's $65-per-share all cash offer to buy the eye care company. Over two thirds of the total shares were voted in favour of the transaction, which is expected to close early in the fourth quarter of 2007. Another merger deal poised to close is Teleflex's $2bn acquisition of Arrow International. Arrow shareholders gave their blessing to the transaction, and voted to re-elect all of Arrow's existing board directors. The deal is slated to close on October 1.